12.3 New-Product Review and Continuing Membership Applications

What Makes a Product New?

A product can be "new" to the firm even if it has existed in the market. New features, riders, guarantees, share classes, distribution channels, target customers, digital tools, compensation or material changes to an existing product can introduce risks the current system does not address. A fund added through a new direct-to-consumer platform may require review even when the fund itself is familiar.

FINRA's new-product guidance, beginning with NASD Notice to Members 05-26, operates through the supervisory duties in Rule 3110 and related conduct rules. The reasonable-basis component of Rule 2111.05(a) and Reg BI's Care Obligation also require diligence matched to a product's complexity and risk; a firm that does not understand a product cannot approve it for recommendation. The firm should define triggers broadly enough that business personnel cannot avoid review by calling a change an enhancement.

Pre-Launch Review

The review should involve compliance, legal, risk, finance, operations, technology, training and business owners. Approval can include customer limitations, concentration caps, enhanced disclosures, principal preapproval or a controlled pilot. A committee vote without documented analysis is not a reasonable process.

Post-Launch Review

Actual sales can disprove assumptions. Review customer profiles, cancellations, redemptions, exchanges, complaints, performance in stress, representative concentration and exceptions. A product that generates repeated overrides or unexpected liquidity harm should be restricted or suspended while the firm investigates. Training completion does not replace outcome testing.

Continuing Membership Applications

FINRA Rule 1017(a) requires a member to file a Continuing Membership Application (Form CMA) for:

1. a merger of the member with another member, subject to an exception tied to NYSE membership;
2. a direct or indirect acquisition by the member of another member;
3. direct or indirect acquisitions or transfers of 25% or more of the member's assets, or of any asset, business or line of operation that generates 25% or more of its earnings measured on a rolling 36-month basis;
4. a change in equity ownership or partnership capital that results in one person or entity directly or indirectly owning or controlling 25% or more;
5. a material change in business operations as defined in Rule 1011; and
6. certain transfers or hires involving pending arbitration claims or unpaid awards and, under Rule 1017(a)(7), associating a person with recent final criminal matters or specified risk events, unless the member first obtains a materiality consultation (Section 1.4).

Timing under Rule 1017(c). A change in ownership or control requires an application at least 30 days before the change; the member may complete the change before FINRA decides, but FINRA may impose interim restrictions. A material change in business operations may not take effect until the proceeding concludes, unless FINRA and the member agree otherwise. An application to remove or modify a membership-agreement restriction may be filed at any time, and the restriction stays in effect while it is pending. If the member or an associated person has an unpaid arbitration award or settlement, the change may not take effect until the member shows it can pay. If FINRA has not served a decision within 180 days after filing, or a later agreed date, the applicant may ask FINRA's Board to direct a decision.

The firm's membership agreement can limit products, customers, offices, personnel, markets, capital or custody. Adding a new line that exceeds those restrictions can require a CMA even if the product committee approves it. Product approval and membership approval are separate gates.

Planning and Implementation

Business leaders should involve membership and regulatory counsel before signing an irreversible transaction or launching operations. The filing describes the change, ownership, management, systems, supervision, capital, financial projections, disciplinary history and ability to meet the membership standards. FINRA may approve, deny or impose restrictions.

Implementation waits for required approval. Afterward, Forms BD, U4, BR, membership records, WSPs, financial requirements and state or insurance filings must be updated. A firm that operates first and seeks permission later can face both a membership violation and customer remediation.

Product Due Diligence Depth

Due diligence should test source documents rather than repeat the issuer's sales presentation. Review governing contracts, registration statements, financial information, service providers, valuation, liquidity, conflicts, disciplinary history and adverse scenarios. For a variable contract, model surrender, rider and subaccount effects; for a fund, examine strategy, pricing, capacity, fees and redemption mechanics.

The firm should define who can stop a launch and how disagreements are resolved. Approval conditions belong in systems wherever possible—for example, blocking an ineligible account rather than relying only on a representative reminder. Exceptions need named authority, reason and duration.

Material-Change Analysis

Rule 1017 analysis should begin with a written before-and-after description of ownership, control, assets, products, revenues, offices, personnel, custody, clearing and capital. Quantitative growth can be material even when the product line is unchanged; a change in who controls the firm can trigger review without operational growth.

Transaction agreements should account for FINRA approval conditions and timing. Closing a control transaction or beginning the new business before approval can be difficult to unwind and does not become permissible because a CMA was later filed.

After a CMA approval, the firm should compare each imposed restriction with system entitlements and supervisory reports. A condition written only in a legal file may be missed by representatives, finance and operations who implement the business.